Hexagon Capital Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $17.8K | Buy |
|
|||||
|
2024
Q4 | $23.7K | Hold |
|
|||||
|
2024
Q3 | $24.1K | Hold |
|
|||||
|
2024
Q2 | $19.7K | Hold |
|
|||||
|
2024
Q1 | $24.9K | Hold |
|
|||||
|
2023
Q4 | $23.2K | Hold |
|
|||||
|
2023
Q3 | $25.8K | Hold |
|
|||||
|
2023
Q2 | $27.3K | Hold |
|
|||||
|
2023
Q1 | $34.5K | Hold |
|
|||||
|
2022
Q4 | $30.3K | Hold |
|
|||||
|
2022
Q3 | $30K | Hold |
|
|||||
|
2022
Q2 | $36K | Hold |
|
|||||
|
2022
Q1 | $41K | Hold |
|
|||||
|
2021
Q4 | $54K | Hold |
|
|||||
|
2021
Q3 | $54K | Hold |
|
|||||
|
2021
Q2 | $46K | Hold |
|
|||||
|
2021
Q1 | $41K | Hold |
|
|||||
|
2020
Q4 | $41K | Hold |
|
|||||
|
2020
Q3 | $42K | Buy |
|